Percentage of Patients With Asthma That Are Given a Written Asthma Action Plan at Discharge AND a Copy Is Communicated to the Primary Care Clinician

Identifying Attributes

Care Settings
Care Transitions
Country
Australia
Publishing Organisation
Australian Commission on Safety and Quality in Health Care (ACSQHC): National Quality Use of Medicines Indicators for Australian Hospitals (2014)
Type of Quality Indicator
Process
IOM Quality Dimension
Person-Centredness
Setting-Specific Domain
Communication

Defining Attributes

Definition

Percentage of patients with asthma that were given a written asthma action plan at discharge AND a copy was communicated to the primary care clinician. A written asthma action plan should be individualised to the patient's needs and should cover: details of regular maintenance and preventer medicines; how and when to adjust treatment in response to signs and symptoms of exacerbations; how and when to start oral corticosteroids and seek medical advice for increasing asthma severity; and how and when to seek urgent medical help. A copy of the plan given to the patient should be included in the medical record, or explicit documentation made in the medical record that an individualised plan was given. A copy is communicated to the primary care clinician means a copy of the plan is sent to the communityx0002based health practitioner nominated by the patient, or included in the discharge summary or discharge letter. Such communication should be explicitly documented in the medical record.

Numerator

Number of patients with asthma that were given a written asthma action plan at discharge AND a copy was communicated to the primary care clinician

Denominator

Number of patients with asthma in sample

Exclusions

None

Use of Risk Adjustment
No
Risk Adjustments
Stratifications

Collection and Reporting Attributes

Type of Data Collection
Electronic/paper chart records
Data Collection Methods

Medical records and discharge documentation.

Frequency of Data Collection
The National QUM Indicators are designed for data collection as part of local quality improvement activities, for use by clinicians involved in hospital medication management, especially doctors, nurses, and pharmacists. The indicators may provide evidence for accreditation purposes.
Frequency of Data Collection in Days
1
Reporting Methods

Recommended for local quality improvement processes. Not regularly reported at national level.

Reporting Frequency
Ad libitum
Reporting Frequency in Days
1
Indicator Has Recommended Targets
No

Source and Reference Attributes

Evidence Source

Australian Commission on Safety and Quality in Health Care and NSW Therapeutic Advisory Group Inc. (2014), National Quality Use of Medicines Indicators for Australian Hospitals. ACSQHC, Sydney www.safetyandquality.gov.au/sites/default/files/migrated/SAQ127NationalQUMIndicatorsV14-FINAL-D14-39602.pdf page 94

Technical Specifications
Link to Measurement Tools
Domain
Not Assigned
Quality Indicator Confirmed to be Part of a Program Used to Monitor Quality and Safety of Care Among Older People at a Population-Level between 2012-2022
No
Assessed by the Australian Consortium for Aged Care Collaborators as Generally Containing Good Properties (Importance and Scientific Acceptability)
No
Australian Consortium for Aged Care Endorsed
No
Can the Quality Indicator be Readily Implemented at a Population Level in Australia Given its Current Data Landscape?
Implementation of this quality indicator was not assessed.
Identified by PHARMA-Care Project
No
Upload Date
23 July 2025